SRGA
Price:
$0.1829
Market Cap:
$1.68M
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of i...[Read more]
Industry
Medical - Devices
IPO Date
2000-08-11
Stock Exchange
NASDAQ
Ticker
SRGA
According to Surgalign Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -79.61% compared to the average of -0.10 of the last 4 quarters.
The mean historical PE Ratio of Surgalign Holdings, Inc. over the last ten years is -145.96. The current -0.02 PE Ratio has changed -98.63% with respect to the historical average. Over the past ten years (40 quarters), SRGA's PE Ratio was at its highest in in the December 2014 quarter at 3.37K. The PE Ratio was at its lowest in in the March 2018 quarter at -2257.69.
Average
-145.96
Median
-0.74
Minimum
-5640.73
Maximum
3.28K
Discovering the peaks and valleys of Surgalign Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 8.60%
Maximum Annual PE Ratio = 3.28K
Minimum Annual Increase = -1078.84%
Minimum Annual PE Ratio = -5640.73
Year | PE Ratio | Change |
---|---|---|
2022 | -0.24 | -66.57% |
2021 | -0.71 | -14.84% |
2020 | -0.84 | 8.60% |
2019 | -0.77 | -99.99% |
2018 | -5640.73 | -581.92% |
2017 | 1.17K | -396.82% |
2016 | -394.34 | -185.72% |
2015 | 460.04 | -85.99% |
2014 | 3.28K | -1078.84% |
2013 | -335.39 | -139.38% |
The current PE Ratio of Surgalign Holdings, Inc. (SRGA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.60
5-year avg
-1128.66
10-year avg
-145.96
Surgalign Holdings, Inc.’s PE Ratio is less than NuVasive, Inc. (68.48), greater than Paragon 28, Inc. (-10.66), greater than Orthofix Medical Inc. (-5.12), greater than SI-BONE, Inc. (-15.32), less than Avanos Medical, Inc. (141.40), greater than Aziyo Biologics, Inc. (-0.75), greater than Establishment Labs Holdings Inc. (-13.95), greater than CVRx, Inc. (-3.35), greater than AxoGen, Inc. (-34.41), greater than Talis Biomedical Corporation (-0.06), greater than Heart Test Laboratories, Inc. (-0.29), greater than Tivic Health Systems, Inc. (-0.19), greater than Bone Biologics Corporation (-0.27), greater than Bioventus Inc. (-14.55), greater than Surmodics, Inc. (-393.30), greater than Biomerica, Inc. (-0.98), greater than Movano Inc. (-1.15), greater than Ainos, Inc. (-0.23), greater than INVO Bioscience, Inc. (-0.38), greater than Hyperfine, Inc. (-1.56), greater than Inogen, Inc. (-2.89), greater than Accelerate Diagnostics, Inc. (-1.05), greater than Apyx Medical Corporation (-1.59),
Company | PE Ratio | Market cap |
---|---|---|
68.48 | $2.08B | |
-10.66 | $609.86M | |
-5.12 | $619.96M | |
-15.32 | $631.67M | |
141.40 | $1.09B | |
-0.75 | $24.21M | |
-13.95 | $1.16B | |
-3.35 | $183.44M | |
-34.41 | $570.66M | |
-0.06 | $2.83M | |
-0.29 | $2.52M | |
-0.19 | $2.03M | |
-0.27 | $2.14M | |
-14.55 | $621.23M | |
-393.30 | $553.99M | |
-0.98 | $5.84M | |
-1.15 | $30.77M | |
-0.23 | $4.42M | |
-0.38 | $2.95M | |
-1.56 | $65.36M | |
-2.89 | $268.02M | |
-1.05 | $40.97M | |
-1.59 | $45.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surgalign Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Surgalign Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Surgalign Holdings, Inc.'s PE Ratio?
How is the PE Ratio calculated for Surgalign Holdings, Inc. (SRGA)?
What is the highest PE Ratio for Surgalign Holdings, Inc. (SRGA)?
What is the 3-year average PE Ratio for Surgalign Holdings, Inc. (SRGA)?
What is the 5-year average PE Ratio for Surgalign Holdings, Inc. (SRGA)?
How does the current PE Ratio for Surgalign Holdings, Inc. (SRGA) compare to its historical average?